Peripheral Vascular Disease and Carotid Artery Disease Are Associated with Decreased Bile Acid Excretion

Lior Charach1,2, Gideon Charach1,2, Eli Karniel1,2

  • 1Department of Internal Medicine B, Meir Medical Center, Kfar Saba 4428164, Israel.

Insights

Low bile acid excretion (BAE) is linked to increased cardiovascular and cerebrovascular disease risk. This study found low BAE is an independent risk factor for peripheral vascular disease (PVD) and predicts survival.

Area of Science:

  • Cardiovascular Science
  • Metabolic Disease Research
  • Gastroenterology

Background:

  • Low bile acid excretion (BAE) is a known risk factor for coronary artery disease (CAD) and cerebrovascular disease (stroke).
  • The association between BAE and peripheral vascular disease (PVD) and carotid artery disease (CA) remains less understood.
  • Atherosclerosis affects multiple vascular beds and impacts patient outcomes.

Purpose of the Study:

  • To investigate bile acid excretion (BAE) in patients with peripheral vascular disease (PVD) and carotid artery disease (CA).
  • To compare BAE levels in patients with atherosclerosis across different vascular beds.
  • To determine the relationship between BAE and long-term survival in a prospective cohort.

Main Methods:

  • Prospective study with 103 patients (66% male, mean age 60.9 years) over 22 years.
  • Fecal BAE measured via gas-liquid chromatography after a 4-day standard diet.
  • Regression analysis and Pearson correlations used to identify predictors of survival and relationships between BAE and other factors.

Main Results:

  • Low BAE (<262.4 mg/24 h) was associated with significantly lower 22-year survival (15%) compared to participants without atherosclerosis (>60% survival).
  • BAE was lower in patients with polyvascular atherosclerosis than in those with involvement of 1-3 vascular beds.
  • Advanced age, total BAE, and main BAE fractions were independent predictors of prolonged survival (p < 0.001).

Conclusions:

  • Low bile acid excretion (BAE) is a significant independent risk factor for peripheral vascular disease (PVD).
  • BAE levels correlate with the extent of atherosclerosis and predict long-term survival.
  • Measuring BAE may aid in assessing cardiovascular risk and patient prognosis.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
152
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485